4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-25-002778
CEO bought 675,000 shares at $0.69 ($467,438)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna CEO | 2025-03-25 | Purchase | +675,000 | $0.69 | $467,438 | 1,999,296 | D |
| Open-market purchases · 675,000 sh · avg $0.69 · $467,438 | |||||||
Loading xslF345X05/primarydocument.xml…